News and Events | Providence

Upcoming Events

Press

Providence Medical Technology Launches DTRAX Bone Screws to U.S. Market

Providence Medical Technology, Inc. today announced the full commercial launch of DTRAX Bone Screws in the U.S. market.

Providence Medical Technology Raises $12 Million Through a Combination of Equity and Debt Financing

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.

Providence Medical Technology Granted CE Mark For Full DTRAX Line of Cervical Spine Products

Providence Medical Technology, Inc. announced today it has obtained a CE Mark for its DTRAX Spinal System, DTRAX Cervical Cage, and DTRAX Bone Screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio.

Providence Medical Technology Announces Expansion of Patent Portfolio

Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.

Providence Medical Technology Secures $3 Million Venture Debt Funding

Providence Medical Technology, Inc. announced today it has closed a $3 million venture debt agreement with East West Bank. The debt facility complements the $6.8 million venture funding that closed earlier in 2014.

Providence Medical Technology Closes Series C Financing

Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.

Providence Medical Technology Announces Availability of Two-Year Data on DTRAX Expandable Cage System (formerly marketed as DTRAX Facet System)

Providence Medical Technology, Inc. (PMT) today announced that two‐year follow‐up data on patients treated with the DTRAX Facet System will be available in the electronic poster session at the Congress of Neurological Surgeons (CNS) Annual Meeting in San Francisco, October 19‐23. This data represents follow‐up to the one‐year results published earlier in 2013 in the Journal of Neurosurgery: Spine.

Providence Medical Technology Awarded Five More Patents for Facet Joint Implants and Methods of Placement

Providence Medical Technology, Inc. (PMT) today announced that five U.S. patents have been issued in the past 12 months protecting the DTRAX® family of technologies, bringing the total number of U.S. patents issued to the company by the U.S. Patent Office to seven.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2024, Providence Medical Technology. All rights reserved.